CSE:ASEP - Post Discussion
Post by
XeniaTechie on Dec 22, 2021 2:22pm
ASEP positioned to deliver urgent unmet needs in a $41.9B mk
Entry appealing for $ASEP at a steady $0.5 - With 15 patents awarded more underway, they are positioned to deliver in a $41.9B global antibiotic market, urgent unmet needs:
-0 approved treatments for biofilms
-2.8M+ antibiotic resistant infections/yr/in US
-Untreatable variants and dangerous pathogens
More info available in their investors deck: https://asepmedical.com/investors/
Be the first to comment on this post